Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Avalyn Pharma has priced its initial public offering (IPO) on the Nasdaq, hoping to raise an upscaled $300 million for its ...

The phase 3 TETON-2 ( NCT05255991) clinical trial assessed inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) and ...

Cash and Cash Investments at December 31, 2025 of €116.5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) ...

PureTech level cash, cash equivalents and short-term investments of $277.1 million 1 and Consolidated cash, cash equivalents and short-term investments of $277.3 million 1 as of D ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

· Scientists find that vigorous exercise may lower the risk of eight chronic diseases. · Even a few minutes of vigorous exercise a day can make a difference, research finds. · Experts explain the ...

For years, public health advice has emphasized a simple message: sit less, move more. On its surface, this is sound advice. However, two new studies using the same data set and published just days ...

Knee stability exercises probably aren’t top of mind when you hit the gym. But having stable knees is super important in a bunch of different scenarios—from running a marathon to climbing the stairs ...

Cipla has received the US FDA's approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the ...

Oceantic Network’s annual International Partnering Forum (IPF) lands in the Big Apple in 2026! IPF is the largest marine renewable energy conference in the Americas, empowering companies to innovate ...

Jakob Roze, CSCS, is a health writer and high-end personal trainer. He is the founder and CEO of RozeFit, a high-end concierge personal training practice and online blog. A strong back supports better ...